These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29179167)

  • 1. [Glucocorticoid-induced abnormality in bone remodeling.].
    Tanaka Y
    Clin Calcium; 2017; 27(12):1731-1738. PubMed ID: 29179167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2014 Sep; 24(9):1289-94. PubMed ID: 25177000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoid and bone metabolism and disease].
    Tanaka Y
    Clin Calcium; 2013 Feb; 23(2):229-35. PubMed ID: 23354090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of corticosteroids on bone metabolism: a review.
    Mitra R
    PM R; 2011 May; 3(5):466-71; quiz 471. PubMed ID: 21570035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of glucocorticoid induced bone changes with beta-ecdysone.
    Dai W; Jiang L; Lay YA; Chen H; Jin G; Zhang H; Kot A; Ritchie RO; Lane NE; Yao W
    Bone; 2015 May; 74():48-57. PubMed ID: 25585248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis.
    Pierotti S; Gandini L; Lenzi A; Isidori AM
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):292-9. PubMed ID: 17950597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast autophagy in glucocorticoid-induced osteoporosis.
    Wang L; Heckmann BL; Yang X; Long H
    J Cell Physiol; 2019 Apr; 234(4):3207-3215. PubMed ID: 30417506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.
    Canalis E
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3441-7. PubMed ID: 8855781
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucocorticoid receptor signaling in bone cells.
    Moutsatsou P; Kassi E; Papavassiliou AG
    Trends Mol Med; 2012 Jun; 18(6):348-59. PubMed ID: 22578718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomorphometric analysis of glucocorticoid-induced osteoporosis.
    Dalle Carbonare L; Bertoldo F; Valenti MT; Zenari S; Zanatta M; Sella S; Giannini S; Cascio VL
    Micron; 2005; 36(7-8):645-52. PubMed ID: 16243531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid aggravates bone micro-architecture deterioration and skeletal muscle atrophy in mice fed on high-fat diet.
    Adhikary S; Kothari P; Choudhary D; Tripathi AK; Trivedi R
    Steroids; 2019 Sep; 149():108416. PubMed ID: 31150681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis.
    Mohan G; Lay EY; Berka H; Ringwood L; Kot A; Chen H; Yao W; Lane NE
    Calcif Tissue Int; 2017 Jan; 100(1):67-79. PubMed ID: 27679514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment.
    Chotiyarnwong P; McCloskey EV
    Nat Rev Endocrinol; 2020 Aug; 16(8):437-447. PubMed ID: 32286516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-29a protects against glucocorticoid-induced bone loss and fragility in rats by orchestrating bone acquisition and resorption.
    Wang FS; Chuang PC; Lin CL; Chen MW; Ke HJ; Chang YH; Chen YS; Wu SL; Ko JY
    Arthritis Rheum; 2013 Jun; 65(6):1530-40. PubMed ID: 23529662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylaxis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-Induced Osteoporosis.
    Frenkel B; White W; Tuckermann J
    Adv Exp Med Biol; 2015; 872():179-215. PubMed ID: 26215995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Action of glucocorticoid on bone-forming and bone-resorbing cells].
    Hakeda Y
    Clin Calcium; 2006 Nov; 16(11):1817-22. PubMed ID: 17079848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.